Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægerne Nordre Jernbanevej 36, 3400 Hillerød I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   8.7% 10.6% 10.9% 9.2% 8.3% 8.7% 11.1% 10.9%   Credit score (0-100)   30 23 21 26 28 28 22 22   Credit rating   BB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   12,395 11,354 11,919 12,359 13,325 12,812 0.0 0.0   EBITDA   8,224 7,274 7,524 7,450 6,709 6,601 0.0 0.0   EBIT   8,127 7,193 7,433 7,339 6,622 6,533 0.0 0.0   Pre-tax profit (PTP)   8,146.6 7,204.0 7,437.7 7,347.7 6,637.3 6,551.0 0.0 0.0   Net earnings   8,146.6 7,204.0 7,437.7 7,347.7 6,637.3 6,551.0 0.0 0.0   Pre-tax profit without non-rec. items   8,147 7,204 7,438 7,348 6,637 6,551 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   278 197 245 167 170 746 0.0 0.0   Shareholders equity total   1,643 193 176 732 972 1,493 1,317 1,317   Interest-bearing liabilities   0.0 0.0 0.0 793 1,146 580 0.0 0.0   Balance sheet total (assets)   2,731 2,432 2,197 1,910 2,444 2,490 1,317 1,317   Net Debt   -1,180 -1,033 -745 210 58.7 -141 -1,317 -1,317     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   12,395 11,354 11,919 12,359 13,325 12,812 0.0 0.0   Gross profit growth   3.0% -8.4% 5.0% 3.7% 7.8% -3.9% -100.0% 0.0%   Employees   16 16 15 17 17 17 0 0   Employee growth %   6.7% 0.0% -6.3% 13.3% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,731 2,432 2,197 1,910 2,444 2,490 1,317 1,317   Balance sheet change%   -14.6% -10.9% -9.7% -13.1% 27.9% 1.9% -47.1% 0.0%   Added value   8,223.8 7,273.9 7,523.8 7,450.3 6,733.8 6,600.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -43 -162 -43 -189 -84 508 -746 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   65.6% 63.3% 62.4% 59.4% 49.7% 51.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   274.8% 279.3% 321.8% 358.2% 304.9% 265.6% 0.0% 0.0%   ROI %   443.3% 785.2% 4,032.3% 864.8% 364.4% 312.6% 0.0% 0.0%   ROE %   443.3% 784.5% 4,026.6% 1,618.4% 779.0% 531.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   60.2% 8.0% 8.0% 39.5% 40.9% 62.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -14.3% -14.2% -9.9% 2.8% 0.9% -2.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 108.3% 117.9% 38.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 1.9% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   2.3 1.0 1.0 1.6 1.6 1.9 0.0 0.0   Current Ratio   2.3 1.0 1.0 1.5 1.5 1.7 0.0 0.0   Cash and cash equivalent   1,180.0 1,033.2 744.8 582.7 1,087.1 720.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,365.1 -3.5 -68.9 564.6 801.9 747.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   514 455 502 438 396 388 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   514 455 502 438 395 388 0 0   EBIT / employee   508 450 496 432 390 384 0 0   Net earnings / employee   509 450 496 432 390 385 0 0